The EVP & GC of Masimo Corp is Exercising Options

By Carrie Williams

Today it was reported that the EVP & GC of Masimo Corp (MASIResearch Report), Thomas Samuel Mcclenahan, exercised options to buy 1,000 MASI shares at $22.40 a share, for a total transaction value of $22.4K.

This recent transaction increases Thomas Samuel Mcclenahan’s holding in the company by 50% to a total of $327.3K.

See today’s analyst top recommended stocks >>

Based on Masimo Corp’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $211 million and quarterly net profit of $57.13 million. In comparison, last year the company earned revenue of $194 million and had a net profit of $39.24 million. MASI’s market cap is $5.78B and the company has a P/E ratio of 41.32. Currently, Masimo Corp has an average volume of 793.1K.

Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $129.00, reflecting a 15.8% upside. Three different firms, including Needham and Stifel Nicolaus, currently also have a Buy rating on the stock.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Masimo Corp. is a medical technology company, which engages in the development and manufacture of non invasive patient monitoring technologies, medical devices, and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography and gas, data download and analytics, and sensors and accessories.